Abstract

The uncontrolled and irrational use of antimicrobial drugs in hospitals and outpatient settings (including at home) has led to the emergence of resistance mechanisms of bacterial strains. The increase in fluoroquinolone resistance rates in the 2020-2021 study proves the widespread use of antibiotics (in this case, fluoroquinolones) to treat secondary infections of bacterial origin or to prevent their occurrence during the COVID-19 pandemic.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call